TGT
54
-3
MOS
48
-2
CB
41
2
PPL
49
2
DLTR
44
-6
PHM
43
6
AEP
56
5
MUR
38
3
HES
61
2
DTE
63
5
AES
39
-2
GME
66
-2
ALL
43
6
TROW
37
5
PBI
35
2
ADT
43
2
VRSK
56
16
THC
50
2
D
53
5
GT
41
-2
TGT
54
-3
MOS
48
-2
CB
41
2
PPL
49
2
DLTR
44
-6
PHM
43
6
AEP
56
5
MUR
38
3
HES
61
2
DTE
63
5
AES
39
-2
GME
66
-2
ALL
43
6
TROW
37
5
PBI
35
2
ADT
43
2
VRSK
56
16
THC
50
2
D
53
5
GT
41
-2
Financhill
Back

SPDR S&P Pharmaceuticals ETF Stock Predictions

Free Stock Analysis Report: Get a clear concise Stock Rating

Analyze Any Stock Free
Sell
40

XPH
SPDR S&P Pharmaceuticals ETF

Last Price:
$42.64
Seasonality Move:
0.54%

7 Day Trial

ALL ACCESS PASS

$ 7

Free Stock Analysis: See What Your Stock is Really Worth

Analyze Any Stock Free

SPDR S&P Pharmaceuticals ETF Stock Forecast

  • Over the next 52 weeks, SPDR S&P Pharmaceuticals ETF has on average historically risen by 6.8% based on the past 18 years of stock performance.
  • SPDR S&P Pharmaceuticals ETF has risen higher in 11 of those 18 years over the subsequent 52-week period, corresponding to a historical accuracy of 61.11%
  • Is SPDR S&P Pharmaceuticals ETF Stock Undervalued?
    The current SPDR S&P Pharmaceuticals ETF [XPH] share price is $42.82. The Score for XPH is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
  • XPH is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.

Will SPDR S&P Pharmaceuticals ETF Stock Go Up Next Year?

  • Over the next 52 weeks, SPDR S&P Pharmaceuticals ETF has on average historically risen by 6.8% based on the past 18 years of stock performance.

SPDR S&P Pharmaceuticals ETF Stock Rating

Sell
40
SPDR S&P Pharmaceuticals ETF (XPH) is a Sell

Is SPDR S&P Pharmaceuticals ETF overpriced?

  • SPDR S&P Pharmaceuticals ETF has risen higher in 11 of those 18 years over the subsequent 52-week period, corresponding to a historical accuracy of 61.11%

SPDR S&P Pharmaceuticals ETF Stock Price History

Is XPH stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and XPH is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:
NYSEARCA
Country:
United States
Industry:
Sector:
Type:
etf
Website:

52-Week Data

52-Week High:
48.76
52-Week Low:
38.88

Prediction Charts

Market Cap:
0
Price in USD:
42.82
Volume:
34.1K
Beta:
0.80

Technical Analysis

SMA50:
45.27
SMA100:
44.88
SMA200:
42.93
52-Wk Change:
-0.19%

Stock Predictions

  • Is SPDR S&P Pharmaceuticals ETF stock public?
    Yes, SPDR S&P Pharmaceuticals ETF is a publicly traded company.
  • What is the SPDR S&P Pharmaceuticals ETF stock quote today?
    The SPDR S&P Pharmaceuticals ETF stock price is 42.82 USD today.
  • How to buy SPDR S&P Pharmaceuticals ETF stock online?
    You can buy SPDR S&P Pharmaceuticals ETF shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Dec-17 44.61 44.66 44.85 44.32
Dec-18 44.68 43.49 44.87 43.19
Dec-19 43.74 43.25 43.88 42.97
Dec-20 43.19 43.42 43.97 43.07
Dec-24 43.42 43.41 43.47 43.08
Dec-26 43.37 44.04 44.05 43.31
Dec-27 43.98 43.49 44.02 43.35
Dec-30 43.10 42.71 43.11 42.45
Dec-31 42.85 42.99 43.11 42.68
Jan-2 43.22 42.64 43.22 42.51
Jan-3 42.76 43.02 43.07 42.76
Jan-6 43.02 42.60 43.07 42.60
Jan-7 42.91 42.85 43.11 42.71
Jan-8 42.50 42.82 42.88 42.22

SPDR S&P Pharmaceuticals ETF Earnings

Data Unavailable

SPDR S&P Pharmaceuticals ETF Forecast Revenue Growth

Data Unavailable

* SPDR S&P Pharmaceuticals ETF stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.